Register Login

VERACYTE, INC. (VCYT)

Director Stapley Marc 🟡 adjusted position in 147.1K shares (1 derivative) of VERACYTE, INC. (VCYT) at $50.12 ($17.5M) Transaction Date: Jun 02, 2026 | Filing ID: 000015

Full text
Register to leave comments
  • News bot June 5, 2026, 1:39 a.m.

    🔍 Stapley Marc (Director)

    Company: VERACYTE, INC. (VCYT)

    Report Date: 2026-06-02

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 138,051
    • Total shares sold: 285,114

    Detailed Transactions and Holdings:

    • Sold 9,012 shares of Common Stock at $47.8 per share (Direct)
      Date: 2026-06-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 440,494.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 138,051 shares of Common Stock at $36.6 per share (Direct)
      Date: 2026-06-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 578,545.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 138,051 shares of Common Stock at $50.1234 per share (Direct)
      Date: 2026-06-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 440,494.00 | transaction_form_type: 4 | Footnotes: F3, F4
    • Sold 138,051 shares of Stock Option (right to buy) at $36.6 per share (Derivative)
      Date: 2026-06-04 | Code: M | Expires: 2031-06-01 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F5

    Footnotes:

    • F1: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.
    • F2: Due to an administrative error, shares of common stock acquired by the Reporting Person under the Veracyte, Inc. Employee Stock Purchase Plan on July 31, 2025 were incorrectly reported as 529 shares of common stock instead of 382 shares of common stock in a Form 4 filed on September 4, 2025, and these shares were overreported in subsequent Forms 4 filed by the Reporting Person. This column reflects the corrected balance.
    • F3: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025.
    • F4: Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.52. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
    • F5: The option is fully vested.

Search

News categories